Cargando…
Mesenchymal Stromal Cell-Based Targeted Therapy Pancreatic Cancer: Progress and Challenges
Pancreatic cancer is an aggressive malignancy with high mortality rates and poor prognoses. Despite rapid progress in the diagnosis and treatment of pancreatic cancer, the efficacy of current therapeutic strategies remains limited. Hence, better alternative therapeutic options for treating pancreati...
Autores principales: | Ma, Zhilong, Hua, Jie, Liu, Jiang, Zhang, Bo, Wang, Wei, Yu, Xianjun, Xu, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966548/ https://www.ncbi.nlm.nih.gov/pubmed/36834969 http://dx.doi.org/10.3390/ijms24043559 |
Ejemplares similares
-
Mesenchymal Stromal Cells and Exosomes: Progress and Challenges
por: Forsberg, Matthew H., et al.
Publicado: (2020) -
Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress
por: Wu, Xiaomo, et al.
Publicado: (2020) -
Role of Damage DNA-Binding Protein 1 in Pancreatic Cancer Progression and Chemoresistance
por: Zhang, Yiyin, et al.
Publicado: (2019) -
Mesenchymal Stromal Cell Therapy for Pancreatitis: A Systematic Review
por: Ahmed, Sara M., et al.
Publicado: (2018) -
Mesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges
por: Najar, Mehdi, et al.
Publicado: (2019)